Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Curtis Huttenhower, Ph.D.

Co-Author

This page shows the publications co-authored by Curtis Huttenhower and Ramnik Xavier.
Connection Strength

6.182
  1. Inflammatory bowel disease as a model for translating the microbiome. Immunity. 2014 Jun 19; 40(6):843-54.
    View in: PubMed
    Score: 0.580
  2. Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease. Nat Microbiol. 2020 03; 5(3):486-497.
    View in: PubMed
    Score: 0.214
  3. Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences. Nat Commun. 2019 07 17; 10(1):3136.
    View in: PubMed
    Score: 0.206
  4. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019 05; 569(7758):655-662.
    View in: PubMed
    Score: 0.204
  5. Bacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and Symbiosis. Cell Host Microbe. 2019 05 08; 25(5):668-680.e7.
    View in: PubMed
    Score: 0.204
  6. Author Correction: Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019 May; 4(5):898.
    View in: PubMed
    Score: 0.203
  7. Publisher Correction: Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life. Nat Microbiol. 2019 Mar; 4(3):545.
    View in: PubMed
    Score: 0.201
  8. Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life. Nat Microbiol. 2019 03; 4(3):470-479.
    View in: PubMed
    Score: 0.198
  9. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019 02; 4(2):293-305.
    View in: PubMed
    Score: 0.198
  10. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature. 2018 10; 562(7728):589-594.
    View in: PubMed
    Score: 0.196
  11. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course. Cell Host Microbe. 2018 10 10; 24(4):600-610.e4.
    View in: PubMed
    Score: 0.196
  12. Strain-Level Analysis of Mother-to-Child Bacterial Transmission during the First Few Months of Life. Cell Host Microbe. 2018 07 11; 24(1):146-154.e4.
    View in: PubMed
    Score: 0.192
  13. Host genetic variation and its microbiome interactions within the Human Microbiome Project. Genome Med. 2018 01 29; 10(1):6.
    View in: PubMed
    Score: 0.186
  14. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat Microbiol. 2018 03; 3(3):337-346.
    View in: PubMed
    Score: 0.186
  15. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med. 2017 Nov 28; 9(1):103.
    View in: PubMed
    Score: 0.184
  16. Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation. Cell Host Microbe. 2017 Jul 12; 22(1):25-37.e6.
    View in: PubMed
    Score: 0.179
  17. Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. Cell. 2016 12 15; 167(7):1897.
    View in: PubMed
    Score: 0.172
  18. Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. Cell. 2016 11 03; 167(4):1125-1136.e8.
    View in: PubMed
    Score: 0.171
  19. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med. 2016 06 15; 8(343):343ra81.
    View in: PubMed
    Score: 0.167
  20. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans. Cell. 2016 Jun 02; 165(6):1551.
    View in: PubMed
    Score: 0.166
  21. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans. Cell. 2016 May 05; 165(4):842-53.
    View in: PubMed
    Score: 0.165
  22. Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes. Genome Med. 2016 Feb 17; 8(1):17.
    View in: PubMed
    Score: 0.163
  23. Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. Genome Biol. 2015 Apr 08; 16:67.
    View in: PubMed
    Score: 0.153
  24. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe. 2015 Feb 11; 17(2):260-73.
    View in: PubMed
    Score: 0.152
  25. Complex host genetics influence the microbiome in inflammatory bowel disease. Genome Med. 2014; 6(12):107.
    View in: PubMed
    Score: 0.150
  26. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014 Mar 12; 15(3):382-392.
    View in: PubMed
    Score: 0.142
  27. Functional profiling of the gut microbiome in disease-associated inflammation. Genome Med. 2013; 5(7):65.
    View in: PubMed
    Score: 0.136
  28. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012 Apr 16; 13(9):R79.
    View in: PubMed
    Score: 0.125
  29. Human gut bacteria produce ??17-modulating bile acid metabolites. Nature. 2022 Mar; 603(7903):907-912.
    View in: PubMed
    Score: 0.062
  30. Delivery Mode Affects Stability of Early Infant Gut Microbiota. Cell Rep Med. 2020 12 22; 1(9):100156.
    View in: PubMed
    Score: 0.057
  31. The human gut microbiota in people with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2021 05; 22(3-4):186-194.
    View in: PubMed
    Score: 0.056
  32. Global chemical effects of the microbiome include new bile-acid conjugations. Nature. 2020 03; 579(7797):123-129.
    View in: PubMed
    Score: 0.054
  33. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response. Nat Commun. 2019 01 03; 10(1):38.
    View in: PubMed
    Score: 0.050
  34. Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis. Mucosal Immunol. 2019 03; 12(2):491-502.
    View in: PubMed
    Score: 0.049
  35. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018 10; 562(7728):583-588.
    View in: PubMed
    Score: 0.049
  36. Mother-to-Infant Microbial Transmission from Different Body Sites Shapes the Developing Infant Gut Microbiome. Cell Host Microbe. 2018 07 11; 24(1):133-145.e5.
    View in: PubMed
    Score: 0.048
  37. A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunol. 2019 03; 12(2):457-467.
    View in: PubMed
    Score: 0.047
  38. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study. Lancet. 2017 04 29; 389(10080):1710-1718.
    View in: PubMed
    Score: 0.044
  39. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut. 2018 01; 67(1):108-119.
    View in: PubMed
    Score: 0.043
  40. Paneth cell defects in Crohn's disease patients promote dysbiosis. JCI Insight. 2016 06 02; 1(8):e86907.
    View in: PubMed
    Score: 0.042
  41. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 2016 Apr 29; 352(6285):565-9.
    View in: PubMed
    Score: 0.041
  42. O-011 Paneth Cell Phenotypes Define a Subtype of Pediatric Crohn's Disease Through Alterations in Host-Microbial Interactions. Inflamm Bowel Dis. 2016 Mar; 22 Suppl 1:S4.
    View in: PubMed
    Score: 0.041
  43. Corrigendum. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest. 2015 Mar 02; 125(3):1363.
    View in: PubMed
    Score: 0.038
  44. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest. 2014 Aug; 124(8):3617-33.
    View in: PubMed
    Score: 0.036
  45. Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses. J Innate Immun. 2014; 6(3):253-62.
    View in: PubMed
    Score: 0.034
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.